Entera Bio Ltd. — Director's Dealing 2022

Jul 25, 2022

SEC Form 3/A — Form 3/A

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: Ellis Sean (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares, par value NIS 0.0000769 per share	7200	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (right to buy)	$5.85	2023-07-02	Ordinary Shares, par value NIS 0.0000769 per share (3000)		Direct

Footnotes

F1: This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted ordinary shares directly held by the Reporting Person.

F2: This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted warrants to purchase ordinary shares directly held by the Reporting Person.